Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Johansson

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cancer Letters|June 30, 2025
Corrigendum to "Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer" [Cancer Lett 609 (2025) 217352]Loïc Steiner, Maria Eldh, Annemarijn Offens, et al.
Cancer Letters|March 6, 2025
Corrigendum to "Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer" [Cancer Lett. 609 (2025) 217352]Loïc Steiner, Maria Eldh, Annemarijn Offens, et al.
Cardiovascular Research|March 5, 2025
Antisense-mediated regulation of exon usage in the elastic spring region of Titin modulates sarcomere functionSelvi Celik, Ludvig Hyrefelt, Tomasz Czuba, et al.
Cancer Letters|November 25, 2024
Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancerLoïc Steiner, Maria Eldh, Annemarijn Offens, et al.
Plos One|July 3, 2018
Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathwayCiputra Adijaya Hartana, Emma Ahlén Bergman, A Ali Zirakzadeh, et al.
European Urology|July 21, 2018
Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder CancerDavid Krantz, Ciputra Adijaya Hartana, Malin E Winerdal, et al.
Cancer Immunology Research|March 29, 2018
Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate InvasivenessMalin E Winerdal, David Krantz, Ciputra A Hartana, et al.
Clinical Immunology (Orlando, Fla.)|December 28, 2016
Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancerA Ali Zirakzadeh, Johan Kinn, David Krantz, et al.
Cells|August 28, 2024
Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 InhibitorCláudia Correia, Jonas Christoffersson, Sandra Tejedor, et al.
Clinical Epigenetics|August 5, 2018
Increased CD4<sup>+</sup> T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patientsEmma Ahlén Bergman, Ciputra Adijaya Hartana, Markus Johansson, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cancer Letters|June 30, 2025
Corrigendum to "Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer" [Cancer Lett 609 (2025) 217352]Loïc Steiner, Maria Eldh, Annemarijn Offens, et al.
Cancer Letters|March 6, 2025
Corrigendum to "Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer" [Cancer Lett. 609 (2025) 217352]Loïc Steiner, Maria Eldh, Annemarijn Offens, et al.
Cardiovascular Research|March 5, 2025
Antisense-mediated regulation of exon usage in the elastic spring region of Titin modulates sarcomere functionSelvi Celik, Ludvig Hyrefelt, Tomasz Czuba, et al.
Cancer Letters|November 25, 2024
Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancerLoïc Steiner, Maria Eldh, Annemarijn Offens, et al.
Plos One|July 3, 2018
Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathwayCiputra Adijaya Hartana, Emma Ahlén Bergman, A Ali Zirakzadeh, et al.
European Urology|July 21, 2018
Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder CancerDavid Krantz, Ciputra Adijaya Hartana, Malin E Winerdal, et al.
Cancer Immunology Research|March 29, 2018
Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate InvasivenessMalin E Winerdal, David Krantz, Ciputra A Hartana, et al.
Clinical Immunology (Orlando, Fla.)|December 28, 2016
Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancerA Ali Zirakzadeh, Johan Kinn, David Krantz, et al.
Cells|August 28, 2024
Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 InhibitorCláudia Correia, Jonas Christoffersson, Sandra Tejedor, et al.
Clinical Epigenetics|August 5, 2018
Increased CD4<sup>+</sup> T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patientsEmma Ahlén Bergman, Ciputra Adijaya Hartana, Markus Johansson, et al.
Pageof 4